ENSG00000204843 Expression In 33 Tumors

Ensembl ID Gene symbol Log2 Foldchange Pvaue Cancer
ENSG00000204843 -0.5 9.32e-15 COAD
ENSG00000204843 -2.1 8.41e-23 GBM
ENSG00000204843 -0.5 5.40e-11 STAD
Ensembl ID Gene symbol Cancer types Pubmed ID
ENSG00000204843 tumour 15813965
ENSG00000204843 tumors 1709208
ENSG00000204843 cancers 25930914
ENSG00000204843 tumor 26062823
ENSG00000204843 primary cancer 26330360
ENSG00000204843 tumor 27689404
ENSG00000204843 tumors 29864111
ENSG00000204843 COAD 30510450
Ensembl ID Gene symbol Disease/phenotype Mutation type Mutated / Total samples Literature
ENSG00000204843 melanocytic neoplasm gene_fusion 50.0% (9/18) 1 entry
ENSG00000204843 hepatocellular carcinoma missense_variant 0.9989% (9/901) 1 entry
ENSG00000204843 colorectal adenocarcinoma sequence_alteration 4.306% (49/1138) 1 entry
ENSG00000204843 esophageal squamous cell carcinoma missense_variant 1.037% (7/675) 2 entries
ENSG00000204843 brain glioblastoma sequence_alteration 0.216% (2/926) 1 entry
ENSG00000204843 bile duct adenocarcinoma missense_variant 1.058% (2/189) 1 entry
ENSG00000204843 prostate adenocarcinoma sequence_alteration 1.719% (25/1454) 1 entry
ENSG00000204843 lung adenocarcinoma missense_variant 1.462% (17/1163) 4 entries
ENSG00000204843 colon adenocarcinoma stop_gained 2.632% (19/722) 1 entry
ENSG00000204843 Merkel cell skin cancer missense_variant 13.33% (4/30) 2 entries
ENSG00000204843 gastric adenocarcinoma missense_variant 2.33% (13/558) 2 entries
ENSG00000204843 colon adenocarcinoma sequence_alteration 2.632% (19/722) 3 entries
ENSG00000204843 clear cell renal carcinoma missense_variant 0.4882% (6/1229) 1 entry
ENSG00000204843 inflammatory myofibroblastic tumor gene_fusion 50.0% (1/2) 1 entry
ENSG00000204843 rectal adenocarcinoma missense_variant 2.715% (6/221) 3 entries
ENSG00000204843 prostate carcinoma missense_variant 0.7042% (3/426) 2 entries
ENSG00000204843 prostate adenocarcinoma missense_variant 1.719% (25/1454) 2 entries
ENSG00000204843 gastric intestinal type adenocarcinoma missense_variant 3.529% (3/85) 2 entries
ENSG00000204843 colorectal adenocarcinoma missense_variant 4.306% (49/1138) 3 entries
ENSG00000204843 squamous cell lung carcinoma missense_variant 1.444% (11/762) 1 entry
ENSG00000204843 breast ductal adenocarcinoma missense_variant 2.74% (16/584) 1 entry
ENSG00000204843 ovarian serous adenocarcinoma missense_variant 1.04% (7/673) 1 entry
ENSG00000204843 basal cell carcinoma missense_variant 3.448% (2/58) 1 entry
ENSG00000204843 skin melanoma missense_variant 2.172% (21/967) 4 entries
ENSG00000204843 colon adenocarcinoma missense_variant 2.632% (19/722) 4 entries
ENSG00000204843 cecum adenocarcinoma missense_variant 4.8% (6/125) 1 entry
ENSG00000204843 melanoma missense_variant 2.97% (3/101) 2 entries
ENSG00000204843 bladder transitional cell carcinoma missense_variant 0.7299% (1/137) 1 entry
ENSG00000204843 adrenocortical adenoma missense_variant 2.5% (1/40) 1 entry
ENSG00000204843 small intestinal neuroendocrine tumor G1 stop_gained 2.381% (1/42) 1 entry
ENSG00000204843 Ampulla of Vater Carcinoma missense_variant 1.176% (1/85) 1 entry
ENSG00000204843 chronic lymphocytic leukemia missense_variant 0.1126% (1/888) 1 entry
ENSG00000204843 small cell lung carcinoma missense_variant 0.3155% (1/317) 1 entry
ENSG00000204843 lung adenocarcinoma sequence_alteration 1.462% (17/1163) 1 entry
ENSG00000204843 central nervous system primitive neuroectodermal neoplasm missense_variant 0.4505% (2/444) 1 entry
ENSG00000204843 nasopharyngeal squamous cell carcinoma missense_variant 0.5988% (1/167) 1 entry
ENSG00000204843 acute myeloid leukemia stop_gained 0.2205% (2/907) 1 entry
ENSG00000204843 head and neck squamous cell carcinoma missense_variant 0.1597% (1/626) 1 entry
ENSG00000204843 esophageal adenocarcinoma missense_variant 0.9132% (4/438) 1 entry
ENSG00000204843 basal cell carcinoma sequence_alteration 3.448% (2/58) 1 entry
ENSG00000204843 glioma stop_gained 0.3454% (2/579) 1 entry
ENSG00000204843 Pancreatic Acinar Cell Carcinoma missense_variant 5.0% (1/20) 1 entry
ENSG00000204843 Gallbladder Adenocarcinoma missense_variant 1.149% (1/87) 1 entry
ENSG00000204843 Invasive Breast Carcinoma sequence_alteration 2.222% (1/45) 1 entry
ENSG00000204843 glioma sequence_alteration 0.3454% (2/579) 1 entry
ENSG00000204843 gastric intestinal type adenocarcinoma stop_gained 3.529% (3/85) 1 entry
ENSG00000204843 ovarian serous adenocarcinoma stop_gained 1.04% (7/673) 1 entry
ENSG00000204843 clear cell renal carcinoma sequence_alteration 0.4882% (6/1229) 1 entry
ENSG00000204843 female breast carcinoma missense_variant 0.3745% (1/267) 1 entry
ENSG00000204843 Ampulla of Vater Carcinoma frameshift_variant 1.176% (1/85) 1 entry
ENSG00000204843 diffuse gastric adenocarcinoma sequence_alteration 1.266% (1/79) 1 entry
ENSG00000204843 non-small cell lung carcinoma stop_gained 1.887% (1/53) 1 entry
ENSG00000204843 urothelial carcinoma missense_variant 100.0% (1/1) 1 entry
Ensembl ID Gene symbol Cancer P-value Which worse show
ENSG00000204843 MESO 0.014 high
ENSG00000204843 SARC 0.022 high
ENSG00000204843 CHOL 0.016 low
ENSG00000204843 PAAD 0.042 low
ENSG00000204843 UCEC 0.026 low
ENSG00000204843 THCA 0.0078 high
ENSG00000204843 LGG 0.028 low
ENSG00000204843 KIRP 0.043 low
ENSG00000204843 KICH 0.0071 high
ENSG00000204843 LUAD 0.0073 low
ENSG00000204843 THYM 0.00059 low
ENSG00000204843 COAD 0.00052 high
ENSG00000204843 UCS 0.024 high
ENSG00000204843 ESCA 0.016 low
ENSG00000204843 OV 0.0024 high
ENSG00000204843 BLCA 0.002 high
ENSG00000204843 LAML 4e-04 high
ENSG00000204843 SKCM 0.0032 high
ENSG00000204843 LIHC 0.0019 high
Ensembl ID Gene symbol Cancer CNV type -log10(q-value) G-score average amplitude frequency